The move marks a reversal of the administration’s original plans to share 60 million doses of AstraZeneca’s vaccine, which has not yet been cleared for use in the U.S.Read More

The move marks a reversal of the administration’s original plans to share 60 million doses of AstraZeneca’s vaccine, which has not yet been cleared for use in the U.S.Read More